Saab, Sammy <br/><br/>
Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients.  [electronic resource] 

 -  Liver international : official journal of the International Association for the Study of the Liver  Nov 2015 
 - 2442-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1478-3231 
<br/><br/><label>Standard No.: </label>10.1111/liv.12856  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antiviral Agents--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Hepacivirus<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Liver Transplantation<br/>Male<br/>Middle Aged<br/>RNA, Viral--blood<br/>Recurrence<br/>Regression Analysis<br/>Retrospective Studies<br/>Simeprevir--adverse effects<br/>Sofosbuvir--adverse effects<br/>Transplant Recipients<br/>Treatment Outcome<br/>Viral Load